跳至主要内容
临床试验/KCT0002512
KCT0002512招募中未知

Phase II, randomized, double-blind clinical trial for efficacy of Granulocyte-colony stimulating factor(G-CSF) and autologous cord blood infusion in children with cerebral palsy

Hanyang University Seoul Hospital0 个研究点目标入组 98 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
98

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
2(Year) 至 10(Year)(—)
性别
All

入选标准

  • ¦A patient who was diagnosed with a mild case, and severity case of cerebral palsy or developmental disability through developmental assessment from more than two specialists including a specialist in pediatrics and rehabilitation medicine
  • ¦Aged 2~10(in full)
  • ¦In case there is a sign of the general decrease in white matter, or periventricular leukomalacia near cerebral ventricles in MRI-DTI(photographed before a clinical trial)test
  • ¦A subject who did a written consent to participation in this clinical trial through the very person and a legal representative-a guardian

排除标准

  • ¦ In case a patient underwent a surgical procedure, or was administered medicated medicine which are known to have neuroprotective effects even partially, such as autologous cord blood and erythropoietin, and Granulocyte-colony stimulating factor(G-CSF), etc. within one year before participating in a clinical trial
  • ¦ Accompanied by a serious disease, such as chromosome abnormality, etc.
  • ¦ In case where a patient’s medical condition is judged to be maladapted by a researcher
  • ¦ In case a patient or his/her legal representative doesn’t agree to participation in a clinical trial
  • ¦ A patient having a medical history of hypersensitivity to Granulocyte-colony stimulating factor(G-CSF)
  • ¦ A patient having a predisposition to allergies
  • ¦ A patient having serious disorders in the liver, kidney, and cardiopulmonary function

研究者

发起方
Hanyang University Seoul Hospital

相似试验